Unbranded biosimilar 95% below the cost of Humira available through the Bayvrio Marketplace
Unbranded Humira® biosimilar available to any hospital or licensed specialty pharmacy in the U.S.
Insights
Breaking the Bundle
Download our Breaking the Bundle white paper to learn how unbundling is gaining momentum.
Bayvrio offers unbranded biosimilar to expand payer choice, access, and affordability
Bayvrio Marketplace adds unbranded Stelara® biosimilar, expanding flexibility and value for healthcare payers
First-of-its-kind marketplace gives payers full control over pharmacy benefits
Bayvrio launches first-of-its-kind marketplace that provides healthcare payers with greater choice, flexibility, and control
Investment accelerates rollout of advanced technology and curated solutions
MedImpact investment in Bayvrio accelerates development and launch of groundbreaking healthcare solutions marketplace
